Analysis of novel in vivo derived Plasmodium falciparum transcriptional profiles
新型体内恶性疟原虫转录谱分析
基本信息
- 批准号:7759387
- 负责人:
- 金额:$ 17.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-07-15 至 2013-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Infection with the malaria parasite Plasmodium falciparum leads to widely different clinical conditions in children - ranging from mild flu-like symptoms to coma and death. Despite the immense medical implications, the genetic and molecular basis of this diversity remains largely unknown. We hypothesize that parasites residing in the human host have needed to adapt to this specialized environment that varies in temperature, substrate and immune response. To characterize parasite biology we have utilized whole genome analysis of the parasite from fresh blood samples of infected patients. With this approach we have identified three biologic states of the parasite when it resides in the human host. One of these in vivo states correlates highly to the laboratory grown transcriptional profile, and now we have identified two novel states. The biological basis of these states can be interpreted by comparison with an extensive compendium of expression data in the yeast, Saccharomyces cerevisiae. The three states in vivo closely resemble (i) active growth based on glycolytic metabolism "the in vitro like state"; (ii) a starvation response accompanied by oxidative phosphorylation; and (iii) an environmental stress response. The results reveal a previously unknown physiological diversity in the in vivo biology of the malaria parasite, in particular, evidence for functional mitochondria in the asexual stage parasite, and point to in vivo and in vitro studies to determine how this variation may impact disease manifestations and treatment. This work highlights the importance of working with human samples to explore clinically relevant parasite biology. Through further clinical studies we propose to 1) identify the host factors that are associated with these novel biologic states 2) identify parasite biology that is specifically found in severe disease 3) test environmental responses of the parasite under controlled conditions using the in vitro model. We are developing a completely novel model for the host pathogen interaction in this parasite. The clinical studies inform the in vitro model and conversely, results of this model can then be tested prospectively in the clinical studies. Furthermore we have developed team of leaders in clinical malaria, computational biology and molecular biology to combine their skills to further our understanding of disease. The long term goal is to identify parasite biology that can be targeted to reduce individual and global health burden of Plasmodium falciparum. PUBLIC HEALTH RELEVANCE: Plasmodium falciparum causes infections in humans which range from asymptomatic to highly severe illness often leading to death. Why some patients have severe disease and others are completely well remains poorly understood, and this may be related to specialized parasite biology that occurs in humans. Through the use of genomics, we have identified completely new parasite biology when it resides in humans and this project will determine if this novel biology is related to differences in disease outcomes. This study brings together experts in computational biology and malaria epidemiology to develop clinically relevant models of parasite biology to inform disease interventions to reduce the impact of malaria infection on individual and global health.
描述(由申请人提供):感染疟疾寄生虫恶性疟原虫导致儿童的临床症状差异很大-从轻微的流感样症状到昏迷和死亡。尽管存在巨大的医学意义,但这种多样性的遗传和分子基础在很大程度上仍然未知。我们假设寄生在人类宿主体内的寄生虫需要适应这种特殊的环境,这种环境在温度,底物和免疫反应方面都有所不同。为了表征寄生虫生物学,我们利用了来自感染患者的新鲜血液样本的寄生虫的全基因组分析。通过这种方法,我们已经确定了寄生虫在人类宿主中的三种生物学状态。其中一种体内状态与实验室生长的转录谱高度相关,现在我们已经确定了两种新的状态。这些状态的生物学基础可以通过与酵母(Saccharomyces cerevisiae)中广泛的表达数据纲要进行比较来解释。体内的三种状态非常类似于(i)基于糖酵解代谢的活性生长“体外样状态”;(ii)伴随氧化磷酸化的饥饿反应;和(iii)环境应激反应。结果揭示了疟疾寄生虫体内生物学中以前未知的生理多样性,特别是无性阶段寄生虫中功能性线粒体的证据,并指出体内和体外研究以确定这种变化如何影响疾病表现和治疗。这项工作强调了与人类样本合作以探索临床相关寄生虫生物学的重要性。通过进一步的临床研究,我们建议1)确定与这些新的生物学状态相关的宿主因素2)确定在严重疾病中特别发现的寄生虫生物学3)使用体外模型在受控条件下测试寄生虫的环境反应。我们正在开发一种全新的模型,在这种寄生虫的宿主病原体相互作用。临床研究为体外模型提供信息,相反,该模型的结果可以在临床研究中进行前瞻性测试。此外,我们还培养了临床疟疾、计算生物学和分子生物学方面的领导者团队,将他们的技能联合收割机结合起来,进一步加深我们对疾病的理解。长期目标是确定可以有针对性地减少恶性疟原虫的个人和全球健康负担的寄生虫生物学。公共卫生关系:恶性疟原虫引起人类感染,其范围从无症状到高度严重的疾病,通常导致死亡。为什么有些患者患有严重疾病,而另一些患者则完全健康,人们对此知之甚少,这可能与人类中发生的特殊寄生虫生物学有关。通过使用基因组学,我们已经确定了完全新的寄生虫生物学,当它驻留在人类和这个项目将确定这种新的生物学是否与疾病结果的差异。这项研究汇集了计算生物学和疟疾流行病学的专家,以开发临床相关的寄生虫生物学模型,为疾病干预提供信息,以减少疟疾感染对个人和全球健康的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Johanna Patricia Daily其他文献
Johanna Patricia Daily的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Johanna Patricia Daily', 18)}}的其他基金
Defining the mechanism of coma in cerebral malaria
定义脑型疟疾昏迷的机制
- 批准号:
10445719 - 财政年份:2022
- 资助金额:
$ 17.62万 - 项目类别:
Characterizing persistent subclinical neurobehavioral effects of COVID-19 in a diverse urban population
表征 COVID-19 对不同城市人群的持续亚临床神经行为影响
- 批准号:
10445841 - 财政年份:2022
- 资助金额:
$ 17.62万 - 项目类别:
Characterizing persistent subclinical neurobehavioral effects of COVID-19 in a diverse urban population
表征 COVID-19 对不同城市人群的持续亚临床神经行为影响
- 批准号:
10580856 - 财政年份:2022
- 资助金额:
$ 17.62万 - 项目类别:
Defining the mechanism of coma in cerebral malaria
定义脑型疟疾昏迷的机制
- 批准号:
10662496 - 财政年份:2022
- 资助金额:
$ 17.62万 - 项目类别:
Identifying adjunctive therapy in the experimental model of malaria to improve cerebral malaria outcomes
确定疟疾实验模型中的辅助治疗以改善脑型疟疾的结果
- 批准号:
10238203 - 财政年份:2021
- 资助金额:
$ 17.62万 - 项目类别:
Identifying adjunctive therapy in the experimental model of malaria to improve cerebral malaria outcomes
确定疟疾实验模型中的辅助治疗以改善脑型疟疾的结果
- 批准号:
10426234 - 财政年份:2021
- 资助金额:
$ 17.62万 - 项目类别:
Role of type INF I during mild Plasmodium falciparum infection and association w
INF I 型在轻度恶性疟原虫感染中的作用及其与 w 的关联
- 批准号:
8472812 - 财政年份:2012
- 资助金额:
$ 17.62万 - 项目类别:
Ethippian Integrated Malaria Research Training Programs Planning Grant
埃塞俄比亚综合疟疾研究培训计划规划补助金
- 批准号:
7933318 - 财政年份:2010
- 资助金额:
$ 17.62万 - 项目类别:
Analysis of novel in vivo derived Plasmodium falciparum transcriptional profiles
新型体内恶性疟原虫转录谱分析
- 批准号:
7888198 - 财政年份:2008
- 资助金额:
$ 17.62万 - 项目类别:
相似国自然基金
基于ex vivo模型联合多组学手段绘制胃癌曲妥珠单抗继发耐药机制并探索克服耐药策略
- 批准号:
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
神经干细胞治疗帕金森病大鼠模型:在体(in vivo)实时记录纹状体多巴胺分泌
- 批准号:81571235
- 批准年份:2015
- 资助金额:57.0 万元
- 项目类别:面上项目
基于in vivo动力学分析的波动环境下黑曲霉产酶得率调控机制研究
- 批准号:21506052
- 批准年份:2015
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
siRNA基因沉默与诱导双向基因治疗关节炎的软骨、滑膜生物学响应及ex vivo系统转基因在体示踪研究
- 批准号:81171774
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
Novel in-vivo ultrasound-based point-of-care instrument to assess myopia level andprogression
用于评估近视程度和进展的新型体内超声护理仪器
- 批准号:
10669915 - 财政年份:2023
- 资助金额:
$ 17.62万 - 项目类别:
Bioorthogonal probe development for highly parallel in vivo imaging
用于高度并行体内成像的生物正交探针开发
- 批准号:
10596786 - 财政年份:2023
- 资助金额:
$ 17.62万 - 项目类别:
Developing novel technologies to analyse cellular differentiation processes during embryonic development in vivo and ex vivo
开发新技术来分析体内和离体胚胎发育过程中的细胞分化过程
- 批准号:
2888341 - 财政年份:2023
- 资助金额:
$ 17.62万 - 项目类别:
Studentship
In vivo calcium imaging during appetitive learning in HIV Tat transgenic mice exposed to cannabis
暴露于大麻的 HIV Tat 转基因小鼠食欲学习过程中的体内钙成像
- 批准号:
10696442 - 财政年份:2023
- 资助金额:
$ 17.62万 - 项目类别:
Noradrenergic gating of astrocyte calcium-mediated homeostasis in vivo
星形胶质细胞钙介导体内稳态的去甲肾上腺素能门控
- 批准号:
10679269 - 财政年份:2023
- 资助金额:
$ 17.62万 - 项目类别:
Novel approach to identify RNA-bound small molecules in vivo
体内鉴定 RNA 结合小分子的新方法
- 批准号:
10646626 - 财政年份:2023
- 资助金额:
$ 17.62万 - 项目类别:
Develop an engineered Cas effector for in vivo cell-targeted delivery in the eye to treat autosomal dominant BEST disease
开发工程化 Cas 效应器,用于眼内体内细胞靶向递送,以治疗常染色体显性 BEST 疾病
- 批准号:
10668167 - 财政年份:2023
- 资助金额:
$ 17.62万 - 项目类别:
In vivo relevance of the Schlafen-mediated innate immune mechanism in flavivirus infection
黄病毒感染中 Schlafen 介导的先天免疫机制的体内相关性
- 批准号:
10629718 - 财政年份:2023
- 资助金额:
$ 17.62万 - 项目类别:
Using in-vivo Real-time Biosensor to Evaluate Prodrugs Designed to Prolong Therapeutic Effects for Smoking Cessation.
使用体内实时生物传感器评估旨在延长戒烟治疗效果的前药。
- 批准号:
10546293 - 财政年份:2023
- 资助金额:
$ 17.62万 - 项目类别:
High-throughput in vivo and in vitro functional and multi-omics screens of neuropsychiatric and neurodevelopmental disorder risk genes
神经精神和神经发育障碍风险基因的高通量体内和体外功能和多组学筛选
- 批准号:
10643398 - 财政年份:2023
- 资助金额:
$ 17.62万 - 项目类别:














{{item.name}}会员




